Background: Late-onset neutropenia (LON) and hypogammaglobulinemia are recognized sequelae of rituximab therapy in B-cell non-Hodgkin lymphoma, and both may leave patients vulnerable to infection once treatment has ended.
Marko Lucijanić +5 more
doaj +1 more source
Correction: Frontline daratumumab, lenalidomide, and dexamethasone in patients older than 80 years with newly diagnosed multiple myeloma: treatment durability, infectious complications, and nutritional vulnerability. [PDF]
Horigome Y +6 more
europepmc +1 more source
IVIG-associated anterior uveitis resolving after switch to subcutaneous immunoglobulin. [PDF]
Schichter Konfino V, Shamriz O.
europepmc +1 more source
Immune Dysregulation and Lymphoma Risk in Deficiency of Adenosine Deaminase 2. [PDF]
Akillioglu M +3 more
europepmc +1 more source
Robotic subxiphoid-optical thymectomy for Good's syndrome in a severely immunocompromised patient: a case report. [PDF]
Kawanishi R +9 more
europepmc +1 more source
Autosomal recessive agammaglobulinemia due to compound heterozygous IGHM alterations identified: a case report. [PDF]
Puente C, Aldave Becerra JC.
europepmc +1 more source
B Cell Aplasia Following CAR T Cell Therapy: Incidence, Kinetics, Prognostic Implications, and Clinical Management. [PDF]
Khalifeh M, Surapaneni M, Salman H.
europepmc +1 more source
Delayed Diagnosis of Common Variable Immunodeficiency Revealed by Recurrent Respiratory Infections and Persistent Mediastinal Lymphadenopathy: A Case Report. [PDF]
Aharmim M +4 more
europepmc +1 more source
Immunoglobulin replacement therapy in antineutrophil cytoplasmic antibody-associated vasculitis with rituximab-associated hypogammaglobulinemia: infection outcomes and disease course in a retrospective cohort. [PDF]
Gross M +4 more
europepmc +1 more source
Hypogammaglobulinemia: Time to Reevaluate? [PDF]
R K, Avery, E A, Blumberg
openaire +2 more sources

